Drug Discovery Partner
We know what it takes to develop a successful drug candidate. We help our customers quickly select the best molecules for further development.
Russell Scammell, Director of Small Molecule Drug Discovery at Charles River, and Eleanor Row, Executive Director of Commercial at Quotient Sciences, talk about the recent Charles River and Quotient Sciences collaboration, and the strengths that each company brings to customer projects to bridge molecules from early discovery to proof of concept (POC) and beyond.
Quotient Sciences can help address the most critical challenges in drug discovery. Contact us today to learn how we can help accelerate your molecules program.